BRPI0820009A2 - Composições nutracêuticas contendo extrato de estévia ou constituintes do extrato de estévia e uso das mesmas - Google Patents

Composições nutracêuticas contendo extrato de estévia ou constituintes do extrato de estévia e uso das mesmas

Info

Publication number
BRPI0820009A2
BRPI0820009A2 BRPI0820009-2A BRPI0820009A BRPI0820009A2 BR PI0820009 A2 BRPI0820009 A2 BR PI0820009A2 BR PI0820009 A BRPI0820009 A BR PI0820009A BR PI0820009 A2 BRPI0820009 A2 BR PI0820009A2
Authority
BR
Brazil
Prior art keywords
stevia extract
constituents
compositions containing
nutraceutical compositions
extract
Prior art date
Application number
BRPI0820009-2A
Other languages
English (en)
Inventor
Ann Fowler
Regina Goralczyk
Claus Kilpert
Annis Olivia Mayne-Mechan
Hasan Mohajeri
Bernd Mussler
Adrian Wyss
Original Assignee
Dsm Ip Assets Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dsm Ip Assets Bv filed Critical Dsm Ip Assets Bv
Publication of BRPI0820009A2 publication Critical patent/BRPI0820009A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/163—Sugars; Polysaccharides
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
    • A23L27/30—Artificial sweetening agents
    • A23L27/33—Artificial sweetening agents containing sugars or derivatives
    • A23L27/36—Terpene glycosides
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Mycology (AREA)
  • Animal Husbandry (AREA)
  • Zoology (AREA)
  • Botany (AREA)
  • Nutrition Science (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Medical Informatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Birds (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Fodder In General (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicinal Preparation (AREA)
BRPI0820009-2A 2007-12-03 2008-12-03 Composições nutracêuticas contendo extrato de estévia ou constituintes do extrato de estévia e uso das mesmas BRPI0820009A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07023334 2007-12-03
PCT/EP2008/010231 WO2009071277A1 (en) 2007-12-03 2008-12-03 Novel nutraceutical compositions containing stevia extract or stevia extract constituents and uses thereof

Publications (1)

Publication Number Publication Date
BRPI0820009A2 true BRPI0820009A2 (pt) 2015-05-19

Family

ID=39512650

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0820009-2A BRPI0820009A2 (pt) 2007-12-03 2008-12-03 Composições nutracêuticas contendo extrato de estévia ou constituintes do extrato de estévia e uso das mesmas

Country Status (13)

Country Link
US (1) US20110038957A1 (pt)
EP (1) EP2214681B1 (pt)
JP (1) JP5584937B2 (pt)
KR (1) KR101574817B1 (pt)
CN (1) CN101883568B (pt)
AU (1) AU2008333570B2 (pt)
BR (1) BRPI0820009A2 (pt)
ES (1) ES2901901T3 (pt)
MY (1) MY155722A (pt)
NZ (1) NZ585720A (pt)
PL (1) PL2214681T3 (pt)
RU (1) RU2519718C2 (pt)
WO (1) WO2009071277A1 (pt)

Families Citing this family (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9107436B2 (en) 2011-02-17 2015-08-18 Purecircle Sdn Bhd Glucosylated steviol glycoside as a flavor modifier
RU2548728C2 (ru) * 2009-07-21 2015-04-20 ДСМ АйПи АССЕТС Б.В. Экстракт stevia или стевиол для ухода за волосами
EP2358730B1 (en) * 2009-10-15 2014-01-15 Purecircle SDN BHD Method for preparing high-purity rebaudioside d
JP2013516963A (ja) 2010-01-19 2013-05-16 ディーエスエム アイピー アセッツ ビー．ブイ． ステビオシドからステビオールを酵素的に調製する方法
US20150344512A1 (en) 2011-12-19 2015-12-03 Purecircle Usa Inc. Methods of purifying steviol glycosides and uses of the same
US10696706B2 (en) 2010-03-12 2020-06-30 Purecircle Usa Inc. Methods of preparing steviol glycosides and uses of the same
WO2011112892A1 (en) * 2010-03-12 2011-09-15 Purecircle Usa Inc. High-purity steviol glycosides
EP2575432B1 (en) 2010-06-02 2019-08-14 Evolva, Inc. Recombinant production of steviol glycosides
ES2659407T3 (es) * 2010-07-23 2018-03-15 Dsm Ip Assets B.V. Uso tópico de esteviol o isoesteviol en el cuidado capilar
US9578895B2 (en) 2010-08-23 2017-02-28 Epc (Beijing) Natural Products Co., Ltd. Rebaudioside A and stevioside compositions
US10238684B2 (en) 2010-11-18 2019-03-26 Foundational Biosystems, Llc Micro- and nano-quantity sleep enhancing nutrient composition and method of enhancing central nervous system protein clearance using same
US8962698B2 (en) 2011-01-28 2015-02-24 Tate & Lyle Ingredients Americas Llc Rebaudioside-mogroside V blends
AU2011356644B2 (en) 2011-01-28 2016-05-19 Tate & Lyle Solutions Usa Llc Stevia blends containing rebaudioside B
US11690391B2 (en) 2011-02-17 2023-07-04 Purecircle Sdn Bhd Glucosylated steviol glycoside as a flavor modifier
WO2012116992A2 (en) * 2011-03-01 2012-09-07 Dsm Ip Assets B.V. Oral use
US9795156B2 (en) 2011-03-17 2017-10-24 E.P.C (Beijing) Plant Pharmaceutical Technology Co., Ltd Rebaudioside B and derivatives
EP2415358A3 (de) * 2011-05-20 2016-06-22 PM-International AG Nahrungsergänzungsmittelpräparat, welches eine Steviakomponente enthält
CN102224897B (zh) * 2011-05-24 2012-11-14 江南大学 一种高水分散性甜菊糖(苷)产品及制备方法
MX364306B (es) 2011-06-20 2019-04-22 Purecircle Usa Inc Composición de estevia.
US9771434B2 (en) 2011-06-23 2017-09-26 Purecircle Sdn Bhd Products from stevia rebaudiana
US20150031765A1 (en) * 2011-08-02 2015-01-29 Maurice Robert CROSS Treatment of cognitive impairment
EP2739274A1 (en) 2011-08-02 2014-06-11 Pensieve Biosciences Cyprus Limited Treatment of cognitive impairment
AU2012294452C1 (en) 2011-08-08 2017-11-30 Danstar Ferment Ag Recombinant production of steviol glycosides
MX377611B (es) 2011-09-07 2025-03-10 Purecircle Usa Inc Edulcorante de estevia altamente soluble.
FR2979819B1 (fr) * 2011-09-09 2014-02-28 Lvmh Rech Nouvelle composition cosmetique comprenant un filtre uv organique hydrophile
FR2979820B1 (fr) * 2011-09-09 2014-01-10 Lvmh Rech Composition cosmetique comprenant un compose amer, un parfum, un edulcorant et un agent gustatif
CN103031283B (zh) * 2011-10-08 2015-07-08 成都华高瑞甜科技有限公司 甜叶菊酶vi及莱鲍迪苷a转化为莱鲍迪苷d的方法
WO2013060746A1 (en) * 2011-10-24 2013-05-02 Givaudan Sa Compositions
US11730683B2 (en) 2011-10-28 2023-08-22 TaylorBaby, LLC Flavored wipe and dispensing system
US9822489B2 (en) 2011-10-28 2017-11-21 TaylorBaby, LLC Flavored wipe and dispensing system
FR2984742A1 (fr) 2011-12-23 2013-06-28 Oreal Utilisation de steviol, d'un derive glycoside du steviol, ou d'un de leurs isomeres, pour prevenir, reduire et/ou traiter une alteration du teint de la peau.
FR2984743B1 (fr) * 2011-12-23 2014-08-22 Oreal Utilisation cosmetique du steviol, d'un derive glycoside du steviol, ou un de leurs isomeres pour stimuler, restaurer ou reguler le metabolisme des cellules de la peau et des semi-muqueuses.
GB201217700D0 (en) 2012-08-01 2012-11-14 Tate & Lyle Ingredients Sweetener compositions containing rebaudioside B
WO2014122227A2 (en) 2013-02-06 2014-08-14 Evolva Sa Methods for improved production of rebaudioside d and rebaudioside m
BR112015019160A2 (pt) 2013-02-11 2017-08-22 Dalgaard Mikkelsen Michael Produção de glicosídeos de esteviol em hospedeiros recombinantes
EP3714699B1 (en) 2013-06-07 2024-12-18 PureCircle USA Inc. Stevia extract containing selected steviol glycosides as flavor, salty and sweetness profile modifier
US10952458B2 (en) 2013-06-07 2021-03-23 Purecircle Usa Inc Stevia extract containing selected steviol glycosides as flavor, salty and sweetness profile modifier
CN104147090B (zh) * 2014-07-04 2018-04-06 新乡医学院 一种治疗抑郁症的药物组合物
CN114410493A (zh) 2014-08-11 2022-04-29 埃沃尔瓦公司 在重组宿主中生产甜菊醇糖苷
WO2016034942A1 (en) 2014-09-02 2016-03-10 Purecircle Usa Inc. Stevia extracts enriched in rebaudioside d, e, n and/or o and process for the preparation thereof
KR20170052647A (ko) 2014-09-09 2017-05-12 에볼바 에스아 재조합 숙주에서 스테비올 글리코시드의 생성
EP3001911A1 (en) 2014-10-03 2016-04-06 Biolittletec, S.L. Composition with stevia rebaudiana bertoni and uses thereof
AU2016211124B2 (en) 2015-01-30 2022-04-14 Danstar Ferment Ag Production of steviol glycosides in recombinant hosts
EP3271457B1 (en) 2015-03-16 2021-01-20 DSM IP Assets B.V. Udp-glycosyltransferases
EP3332018B1 (en) 2015-08-07 2022-07-27 Evolva SA Production of steviol glycosides in recombinant hosts
CN112716930A (zh) * 2015-09-10 2021-04-30 东莞市凯法生物医药有限公司 贝壳杉烷类化合物在制备抑制组织、器官病理性纤维化和重构的药物应用
BR122020008481B1 (pt) 2015-10-26 2022-10-18 Purecircle Usa Inc Composição de glicosídeo de esteviol contendo rebaudiosídeo q glicosilado e rebaudiosídeo r glicosilado e método para melhorar o perfil de doçura de um adoçante de estévia
WO2017106577A1 (en) 2015-12-15 2017-06-22 Purecircle Usa Inc. Steviol glycoside compositions
US12193460B2 (en) 2016-01-07 2025-01-14 Purecircle Usa Inc. Highly soluble steviol glycosides
KR20180132696A (ko) 2016-04-13 2018-12-12 에볼바 에스아 재조합 숙주에서의 스테비올 글리코사이드의 생산
US10815514B2 (en) 2016-05-16 2020-10-27 Evolva Sa Production of steviol glycosides in recombinant hosts
KR102665308B1 (ko) * 2016-10-26 2024-05-10 주식회사 엘지생활건강 레바우디오사이드 a를 포함하는 화장료 조성물
WO2018083338A1 (en) 2016-11-07 2018-05-11 Evolva Sa Production of steviol glycosides in recombinant hosts
EP3525597A1 (en) * 2016-11-11 2019-08-21 Hill's Pet Nutrition, Inc. Compositions and methods of pet food
CN107334974A (zh) * 2017-08-30 2017-11-10 商洛学院 一种益智安神中药提取物及其制备工艺
KR102716073B1 (ko) * 2017-09-21 2024-10-11 서울대학교산학협력단 루부소사이드를 유효성분으로 포함하는 구강 세균 억제용 조성물
AU2020412031A1 (en) * 2019-12-27 2022-07-28 Suntory Holdings Limited New uses for steviol
JP6741262B1 (ja) * 2019-12-28 2020-08-19 Ｏａｔアグリオ株式会社 植物気孔開口促進剤
US20230413879A1 (en) * 2020-11-16 2023-12-28 Isofirms Aps Food comprising isosteviol and uses thereof

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1094892A (zh) * 1994-02-24 1994-11-16 刘家良 寿仙糕
CN1108493A (zh) * 1994-03-16 1995-09-20 熊力夫 灵芝蜂蜜液
JPH1094382A (ja) * 1996-09-20 1998-04-14 Otsuka Yakuhin Kogyo Kk ステビア濃縮液配合による健脳食の製造方法
US6255557B1 (en) * 1998-03-31 2001-07-03 Her Majesty The Queen In Right Of Canada As Represented By The Ministerof Agriculture And Agri-Food Canada Stevia rebaudiana with altered steviol glycoside composition
BE1012249A3 (nl) * 1998-10-27 2000-08-01 Brouwers Louis Jean Hilda Zoetmaker.
JP2001192342A (ja) * 2000-01-07 2001-07-17 Ta Stevia Co Ltd ステビア濃縮液剤および成熟ざくろ混合物の製造方法
JP2003521528A (ja) * 2000-02-01 2003-07-15 ステヴィア，エイプス 食事補強剤、又は非インシュリン依存性糖尿病、高血圧及び／又は代謝症候群の治療のための薬剤の調製に使用する物質
RU2160310C1 (ru) * 2000-02-07 2000-12-10 Курская биофабрика - фирма "БИОК" Концентрированная основа (бальзам)
US7815956B2 (en) * 2001-04-27 2010-10-19 Pepsico Use of erythritol and D-tagatose in diet or reduced-calorie beverages and food products
KR100851610B1 (ko) * 2001-09-21 2008-08-12 디아이씨 가부시끼가이샤 감미료 및 그 제조 방법
CN1505938A (zh) * 2002-12-09 2004-06-23 徐传祥 一种甜叶菊饮品及其原料配比量
JP4345961B2 (ja) * 2003-05-22 2009-10-14 東洋精糖株式会社 ステビア甘味料組成物
CN1917892A (zh) * 2003-10-24 2007-02-21 草本制药科学有限责任公司 包含冬青的方法和组合物
JP2005162634A (ja) * 2003-12-01 2005-06-23 Univ Nihon Ｄｎａ合成酵素阻害剤
JPWO2005089782A1 (ja) * 2004-03-17 2008-01-31 日本キレート株式会社 ステビア発酵液の製造方法、家畜用健康飲料、及び家畜用乳房洗浄剤
JP2005278467A (ja) 2004-03-29 2005-10-13 Nippon Paper Chemicals Co Ltd お茶飲料の味質改善剤およびそれを含有したお茶飲料
RU2283124C1 (ru) * 2005-04-06 2006-09-10 Алексей Глебович Одинец Биологически активный препарат на основе морского растительного сырья
WO2006116815A1 (en) * 2005-05-02 2006-11-09 Vanadis Bioscience Ltd Composition for the control of cholesterol levels
US20070065526A1 (en) * 2005-09-19 2007-03-22 Gow Robert T Methods and compositions comprising Panax species
US8945652B2 (en) * 2005-11-23 2015-02-03 The Coca-Cola Company High-potency sweetener for weight management and compositions sweetened therewith
US20070224292A1 (en) * 2006-03-15 2007-09-27 Brunner Daniel H Extended effect ergogenic drink
CN101049435B (zh) * 2006-04-03 2011-05-18 蹇在金 一种预防中、老年人痴呆营养品的制造方法
CN101024082A (zh) * 2007-04-06 2007-08-29 张士东 一种全面预防和治疗心脑血管疾病复方药及其应用

Also Published As

Publication number Publication date
ES2901901T3 (es) 2022-03-24
EP2214681A1 (en) 2010-08-11
PL2214681T3 (pl) 2022-02-21
KR101574817B1 (ko) 2015-12-04
RU2519718C2 (ru) 2014-06-20
NZ585720A (en) 2012-05-25
KR20100099243A (ko) 2010-09-10
CN101883568B (zh) 2013-12-18
AU2008333570B2 (en) 2013-10-24
RU2010127334A (ru) 2012-01-10
MY155722A (en) 2015-11-30
WO2009071277A1 (en) 2009-06-11
AU2008333570A1 (en) 2009-06-11
JP5584937B2 (ja) 2014-09-10
US20110038957A1 (en) 2011-02-17
CN101883568A (zh) 2010-11-10
JP2011505344A (ja) 2011-02-24
EP2214681B1 (en) 2021-10-20

Similar Documents

Publication Publication Date Title
BRPI0910852A2 (pt) composições contendo lipídios e métodos de uso das mesmas
NO2022027I1 (no) Combination of daunorubicin and cytarabine
BRPI0912717A2 (pt) Composição farmacêutica, e, uso de 5-azacitidina
BRPI0813627A2 (pt) Peptídio antimicrobiano, composições e métodos de uso
SMT201600388B (it) Ligandi leganti opsina, composizioni e metodi d'uso
BRPI0819299A2 (pt) Uso de composição, e, composição contendo proteína
BRPI0910557A2 (pt) composições farmacêuticas de paclitaxel, análogos de paclitaxel ou conjugados de paclitaxel e métodos relacionados de preparação e uso.
BRPI0813000A2 (pt) Composições terapêuticas e uso das mesmas
BRPI0816350A2 (pt) Composições orais, produtos e métodos de uso
EP2174985A4 (en) Gel composition and cosmeetic preparation with it
BRPI0813955A2 (pt) composições terapêuticas e o uso das mesmas
BRPI0720124A2 (pt) Composições farmacêuticas e seus métodos de uso.
BRPI0907575A2 (pt) Ligação de propriedades visuais de gráficos e células dentro de tabelas
EP2167043A4 (en) NEW USE CO-CRYSTAL COMPOSITIONS
BRPI0914488A2 (pt) "composições de limpeza incluindo siloxanos de sorbitano modificados e uso das mesmas"
BRPI0810435A2 (pt) Composições contendo extrato de magnólia
EP2002263A4 (en) IMMUNOTHERAPY COMPOSITIONS FOR CANCER AND METHODS OF USE
BRPI1011876A2 (pt) "composição farmacêutica estável e métodos de uso da mesma"
FR2946879B1 (fr) Extrait de graines entieres de moringa sp. et son utilisation dans des compositions cosmetiques et/ou dermatologiques.
IL211158B (en) Solid core microcapsular compositions and uses thereof
SI2606874T1 (sl) Novi kozmetični in/ali farmacevtski sestavki in načini njihove uporabe
BRPI0917661A2 (pt) produto que contém macitentan, composição farmacêutica que o contém e uso de macitentan
BRPI0812575A2 (pt) Uso de uma substância, composição cosmética ou dermo-cosmética ou neutracêutica, composição farmacêutica, método de cuidado cosmético, e, sequência de nucleotídeos
BR112012004714A2 (pt) preparação combinada de um extrato de cladódios de opuntia ficus indica e um extrato de folhas de olea europeae, e composição
BRPI0812766A2 (pt) 4-cloro-4-alcóxi-1,1,1-triflúor-2-butanonas, preparação das mesmas e uso das mesmas no preparo de 4-alcóxi-1,1,1-triflúor-3-buten-2-onas

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06I Publication of requirement cancelled [chapter 6.9 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B12B Appeal against refusal [chapter 12.2 patent gazette]